Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum SCYNEXIS Inc SCYX

Healthcare
SCYNEXIS, Inc. is a biotechnology company. It is pioneering medicine to overcome and prevent difficult-to-treat and drug-resistant infections. It develops antifungal platform fungerps, a novel class of antifungal agents called triterpenoids, that are structurally distinct glucan synthase inhibitors and have generally shown in vitro and in vivo activity against a range of human fungal pathogens,... see more

NDAQ:SCYX - Post Discussion

SCYNEXIS Inc > Short Interest...
View:
Post by JonathanJSmith on Jun 25, 2021 10:21am

Short Interest...

Crazy high short interest here ( > 3.6mm shares short). I guess that's why the stock went down upon approval. I'm waiting for the EMEA contract to be finalized; with luck it'll be reported before or on the June 29th investor conference date. If so, an EMEA partnership coupled with the high short interest should light a spark under SCYX.

Cheers,

JJ
Comment by dmacd on Jul 30, 2021 12:34pm
Shorters might have their way for now but once sales start to roll out then they will pay up. There cannot be a lot of downside to warrant taking on the risk of upside on positive roll out news. The company does not need to raise any more cash so max downside might be $6.50/sh and then longs like me will start to load up even more, although I am already overweighted in SCYX. I see 10x potential ...more  
SCYNEXIS Inc